Global Hypertrophic Cardiomyopathy Therapeutics Market to reach US$1.4 bn by 2023 Health Articles | May 26 Leonard Williams Jersey , 2016

Hypertrophic cardiomyopathy (HCM) is a disease of the heart muscles (myocardium) in which thickening of myocardium causes functional impairment. It is a genetic condition caused by mutation in one or more genes and is hereditary in nature.



Transparency Market Research, in its latest report, states that the global hypertrophic cardiomyopathy therapeutics market is anticipated to witness tepid growth over the next seven years. Thoroughly analyzing the performance of the market from 2015 to 2023, the report - titled “Hypertrophic Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share Jordan Jenkins Jersey , Growth, Trends, and Forecast, 2015 - 2023” – reveals that the global hypertrophic cardiomyopathy therapeutics market is forecast to rise from a value of US$1.2 bn in 2014 to US$1.4 bn in 2023, registering a 1.40% CAGR during that time.


?


The rising prevalence of chronic cardiovascular diseases, increased awareness about hypertrophic cardiomyopathy, and the growing demand for effective treatments options are the key factors fueling the hypertrophic cardiomyopathy therapeutics market. However Darron Lee Jersey , technological upgradation in devices such as pacemakers and defibrillators hampers the demand for hypertrophic cardiomyopathy drugs.


?


In order to provide readers with a clear understanding of the structure, scope, and dynamics of the hypertrophic cardiomyopathy therapeutics market, the report segments the overall market based on drug class and geography.


?


On the basis of drug class, the hypertrophic cardiomyopathy therapeutics market is categorized into calcium channel blockers, anticoagulants, beta adrenergic blocking agents ArDarius Stewart Jersey , and antiarrhythmic agents. By revenue, calcium channel blockers held the largest share in 2014 and this trend is likely to continue through 2023 with the segment expanding at a 1.80% CAGR during that time. By demand, beta adrenergic blocking agents dominated the market given that they are the first choice for treatment of obstructive and non-obstructive hypertrophic cardiomyopathy.


?


On the basis of geography, the global hypertrophic cardiomyopathy therapeutics market is segmented into North America, Europe, Asia Pacific, and Rest of the World. Accounting for over 30.0% of the overall market in 2014 Marcus Maye Jersey , the US emerged as the leading regional segment of the hypertrophic cardiomyopathy therapeutics market, with Europe following suit. Both these markets are fueled by the rising obese population, availability of modern healthcare infrastructure, high awareness about hypertrophic cardiomyopathy, and sedentary lifestyle among the youth. Asia Pacific is projected to be the fastest developing regional segment of the hypertrophic cardiomyopathy therapeutics market by 2023 owing to development of healthcare infrastructure, increased prevalence of the cardiac ailments and complications, and growing awareness.


?


Request A Sample Of This Report: http:www.transparencymarketresearchsamplesamp...g=S&rep_id=7553


?


An interesting feature of the report on the hypertrophic cardiomyopathy therapeutics market is its assessment of the vendor landscape. Major competitors are identified and examined in detail. Some of the key players competing in the global hypertrophic cardiomyopathy therapeutics market are Gilead Sciences Jamal Adams Jersey , Inc., Astra Zeneca plc, Novartis AG, Mylan N.V., Concordia Healthcare Corp., Teva Pharmaceutical Industries Ltd., Pfizer Sam Darnold Jersey , Inc., Sanofi S.A., and Merck & Co., Inc. These competitors are profiled in the report based on attributes such as company and financial overview, product portfolio, recent developments, and business strategies.


Global Hypertrophic Cardiomyopathy Therapeutics Joe Namath Jersey , by Drug Class

Beta Adrenergic Blocking Agents Calcium Channel Blockers Antiarrhythmic Agents Anticoagulants

Global Hypertrophic Cardiomyopathy Therapeutics, by Geography

North America S. Canada Europe K. Germany Rest of Europe Asia Pacific India Japan Rest of Asia Pacific Rest of the World Latin America Middle East Africa

?


?




Albany




USA - Canada Toll Free 866-552-3453


Email:??sales@transparencymarketresearch


Website:? http:www.transparencymarketresearch

Looking for High School Science software and learning tools to prepare subject then you are at right place. Ask Archie is best site from where you can find various tools and support which help you in preparing math and science subject. Those who struggle to understand key Maths and Science principles, concepts, they can understand easily from our software where you can find online tutoring, past papers Trevon Wesco Jersey , revision classes - students can learn best when, they are able to follow at their own pace and try to follow instruction. Best tools and software for those students who can鈥檛 understand the concept in the class at school. Their Creating activities and best program for math and science preparation make it superb feature software. Students can measure and represent data easily using tables and graphs, it help students develop the math skills that are critical to success.
Ask Archie is a supplementary learning tool and best software which complements the existing structures in place and allows aspiring learners to "focus" in own time. Our effective tutoring, past papers, revision & practices, which help you to understand the concept and close collaboration with classroom teachers, and quality tutor train. Jordan For Sale Wholesale Soccer Jerseys Cheap Jerseys China Cheap NFL Jerseys Cheap NFL Jerseys Cheap NFL Jerseys Cheap NFL Jerseys China Cheap NFL Jerseys China Wholesale NHL Jerseys China Cheap NFL Football Jerseys